Recruiting NA INTERVENTIONAL 2-arm
NCT07187544
Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery
Effect of Co-administration of Carbetocin and Calcium Chloride on Uterine Tone in Patients Undergoing Elective Cesarean Delivery: a Double-blind Randomized Control Trial
Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Conditions
Postpartum Hemorrhage (Primary)
Interventions
Calcium Chloride Carbetocin Placebo
Updated 1 time since 2025 Last updated: Sep 15, 2025 Started: Sep 30, 2025 Primary completion: Sep 30, 2026 Completion: Sep 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This NA trial investigates Postpartum Hemorrhage (Primary) and is currently actively recruiting participants. Samuel Lunenfeld Research Institute, Mount Sinai Hospital leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Data source: Samuel Lunenfeld Research Institute, Mount Sinai Hospital
For direct contact, visit the study record on ClinicalTrials.gov .